Innovative Research Reagents for Inflammation & Immune Responses
Toggle Nav
New Products Archive |
|
Latest Product Highlights ArchiveNew GDF15 Blocking Antibody for Metabolism & Aging Research
|
News & Press ReleasesIL-27 as a New Immunotherapeutic Target in chronic HBV Infection A recent study published in Nature Immunology and led by Dr. Matteo Iannacone (San Raffaele Research Institute, Italy) describes how HBV-specific CD4+ effector T cells regulate the HBV-specific CD8+ T cells during chronic HBV infection and suggests that IL-27 may have therapeutic potential. Abcalis and AdipoGen Life Sciences Partner on Distributing Animal-free Recombinant Monoclonal and Multiclonal Antibodies on the Life Science Research Market |
Collaborating with |
|


























